Vorsetuzumab

Vorsetuzumab
Monoclonal antibody
Type ?
Target CD70
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
Formula C6476H10006N1726O2028S50
Molar mass 146.1 kg/mol

Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics, designed for the treatment of cancer.[1]

Chemical names are:

  1. Immunoglobulin G1, anti-(CD antigen CD70) (human-mouse monoclonal h1F6 heavy chain), disulfide with human-mouse monoclonal h1F6 light chain, dimer
  2. Immunoglobulin G1, anti-(human CD70 antigen (CD27 ligand, Tumor necrosis

See also

References

  1. ↑ http://www.ama-assn.org/resources/doc/usan/vorsetuzumab.pdf



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.